Pacifico Biolabs Raises €7M Series A

Pacifico Biolabs raised €7M in a Series A round announced on May 27, 2026. Pacifico Biolabs specialises in the cultivation of microorganisms, focusing on developing ‘whole-muscle’ structures as sustainable and nutritious alternatives to traditional fish products.

Published Oct 1, 2026

Round size

€7M

Stage

Series A

Headquarters

Germany

Announced

May 27, 2026

The company

Pacifico Biolabs specialises in the cultivation of microorganisms, focusing on developing ‘whole-muscle’ structures as sustainable and nutritious alternatives to traditional fish products.

The funding

Pacifico Biolabs, based in Berlin, Germany, announced €7M in Series A financing on May 27, 2026.

Participants include FoodLabs, Simon Capital, Sprout & About Ventures, Technologie Gründerfonds Sachsen (TGFS), regional brewery partner, Stray Dog Capital.